MetaADEDB 2.0 @ LMMD
Cefixime
(OKBVVJOGVLARMR-QSWIMTSFSA-N)
Structure
SMILES
Nc1nc(cs1)/C(=N/OCC(=O)O)/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C=C
Type(s)
Approved; Investigational
ATC code(s)
J01DD08
Molecular Formula:
C16H15N5O7S2
Molecular Weight:
453.450
Log P:
0.3652
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
4
TPSA:
238.05
CAS Number(s):
79350-37-1
Synonym(s)
1.
Cefixime
2.
Cefixime Anhydrous
3.
Cefixime Trihydrate
4.
FK 027
5.
FK-027
6.
FR-17027
7.
Suprax
8.
FK027
9.
FR 17027
10.
FR17027
External Link(s)
MeSHD020682
PubChem Compound5362065
BindingDB50292241
84007
ChEBI472657
CHEMBLCHEMBL1541
DrugBankDB00671
DrugCentral537
KEGGcpd:C06881
dr:D00258
Therapeutic Target DatabaseD06OVY
ZINC12503147
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ErythemaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
2Clostridium difficile colitisFAERS: 4
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
3HypersensitivityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
4UrticariaFAERS: 4
Canada Vigilance: 3
24329898CTD
SIDER
Canada Vigilance
US FAERS
5ArthralgiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
6PruritusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7VomitingFAERS: 3
Canada Vigilance: 8
1906097CTD
SIDER
Canada Vigilance
US FAERS
8Weight decreasedFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
9Abdominal PainFAERS: 2
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
10AngioedemaFAERS: 2OFFSIDES
SIDER
US FAERS
11AstheniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Chest discomfortFAERS: 2US FAERS
13Clostridium colitisFAERS: 2US FAERS
14Joint swellingFAERS: 2US FAERS
15Lip swellingFAERS: 2US FAERS
16MalaiseFAERS: 2US FAERS
17NauseaFAERS: 2
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
18PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
19Palmar erythemaFAERS: 2OFFSIDES
US FAERS
20PapuleFAERS: 2US FAERS
21Serum SicknessFAERS: 2SIDER
US FAERS
22Serum sickness-like reactionFAERS: 2US FAERS
23SwellingFAERS: 2US FAERS
24Abdominal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
25AnorexiaFAERS: 1OFFSIDES
US FAERS
26AnxietyFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
27ArthritisFAERS: 1US FAERS
28AscitesFAERS: 1US FAERS
29BlindnessFAERS: 1US FAERS
30CataractFAERS: 1US FAERS
31Chest PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
32CholestasisFAERS: 1SIDER
US FAERS
33Cold sweatFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
34ColitisFAERS: 1SIDER
US FAERS
35Corneal OpacityFAERS: 1US FAERS
36DehydrationFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
37DemyelinationFAERS: 1US FAERS
38DizzinessFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
39Erythema MultiformeFAERS: 1SIDER
US FAERS
40Feeling ColdFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Fibrin D dimer increasedFAERS: 1US FAERS
42Fixed eruptionFAERS: 1OFFSIDES
US FAERS
43FlatulenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
44HeadacheFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
45Incorrect drug administration durationFAERS: 1US FAERS
46Irritable Bowel SyndromeFAERS: 1US FAERS
47LeukocytosisFAERS: 1US FAERS
48LeukopeniaFAERS: 1SIDER
US FAERS
49LymphadenitisFAERS: 1US FAERS
50Medication ErrorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
51NeutropeniaFAERS: 1SIDER
US FAERS
52Oculomucocutaneous syndromeFAERS: 1US FAERS
53Oral mucosal erythemaFAERS: 1US FAERS
54PallorFAERS: 1US FAERS
55PemphigusFAERS: 1US FAERS
56PrurigoFAERS: 1US FAERS
57Rash erythematousFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Septic ShockFAERS: 1OFFSIDES
US FAERS
59Skin lesionFAERS: 1OFFSIDES
US FAERS
60SomnolenceFAERS: 1US FAERS
61Stevens-Johnson SyndromeFAERS: 125811541CTD
SIDER
US FAERS
62StomatitisFAERS: 1US FAERS
63SyncopeFAERS: 1US FAERS
64Toxic Epidermal NecrolysisFAERS: 1SIDER
US FAERS
65TremorFAERS: 1US FAERS
66Unevaluable eventFAERS: 1US FAERS
67Vascular painFAERS: 1US FAERS
68WheezingFAERS: 1US FAERS
69pseudomembranous colitisFAERS: 1
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
70AcantholysisOFFSIDES
71Accidental overdoseCanada Vigilance: 1Canada Vigilance
OFFSIDES
72Acid refluxOFFSIDES
73Acute otitis mediaOFFSIDES
74AgoraphobiaOFFSIDES
75AgranulocytosisSIDER
76Alanine Aminotransferase IncreasedOFFSIDES
77Anaphylactic shockSIDER
78Anaphylactoid ReactionSIDER
79AtaxiaOFFSIDES
80Autoimmune thrombocytopeniaOFFSIDES
81Biopsy bone marrow abnormalOFFSIDES
82Blood albumin increasedOFFSIDES
83Blood alkaline phosphatase increasedOFFSIDES
84Blood lactate dehydrogenase increasedSIDER
85Blood sodiumOFFSIDES
86BradycardiaOFFSIDES
87Bronchitis2041146CTD
88Congenital tracheomalaciaOFFSIDES
89Conjunctival abrasionOFFSIDES
90Coombs test positiveSIDER
91CryingCanada Vigilance: 1Canada Vigilance
92Cytolytic hepatitisOFFSIDES
93Depressed moodCanada Vigilance: 1Canada Vigilance
94DermatitisSIDER
95DextrocardiaOFFSIDES
96Diarrhea1906097
2041146
CTD
OFFSIDES
97Disease recurrenceOFFSIDES
98DyspepsiaSIDER
99EczemaOFFSIDES
100EnteritisCanada Vigilance: 1Canada Vigilance
101EosinophiliaSIDER
102EpistaxisCanada Vigilance: 1Canada Vigilance
103Erythema NodosumOFFSIDES
104Escherichia coli Infections15466073CTD
105Exanthema1906097CTD
106Expired product administeredCanada Vigilance: 1Canada Vigilance
107FatigueCanada Vigilance: 1Canada Vigilance
108Fatty LiverOFFSIDES
109Gamma-Glutamyltransferase IncreasedOFFSIDES
110GastroenteritisOFFSIDES
111Gastrointestinal PainSIDER
112Gastrointestinal sounds abnormalOFFSIDES
113Haemophilus Infections1906097
2041146
CTD
114HemiplegiaOFFSIDES
115Hepatic artery thrombosisOFFSIDES
116Hepatic necrosisOFFSIDES
117Hepatitis BOFFSIDES
118HepatitisSIDER
119HypersomniaCanada Vigilance: 1Canada Vigilance
120HypophagiaCanada Vigilance: 1Canada Vigilance
121HysterectomyOFFSIDES
122Impaired driving abilityOFFSIDES
123Inappropriate schedule of drug administrationOFFSIDES
124IncontinenceOFFSIDES
125InfectionCanada Vigilance: 1Canada Vigilance
OFFSIDES
126Infusion site mobility decreasedOFFSIDES
127Injection site discomfortOFFSIDES
128Injection site erythemaOFFSIDES
129Intestinal PerforationCanada Vigilance: 1Canada Vigilance
130Lactic dehydrogenase activity increasedSIDER
131Leukopenia neonatalOFFSIDES
132MeningitisSIDER
133Musculoskeletal PainCanada Vigilance: 1Canada Vigilance
134Nephrotic Syndrome10528699CTD
135Otitis Media1906097
1957129
CTD
136PROTHROMBIN TIMEOFFSIDES
137PancytopeniaSIDER
138Peripheral swellingCanada Vigilance: 1Canada Vigilance
139PeritonitisOFFSIDES
140PetechiaeCanada Vigilance: 1Canada Vigilance
141Pharyngitis2041146CTD
142Pharyngolaryngeal PainOFFSIDES
143Pneumococcal Infections1906097CTD
144Pneumococcal sepsisOFFSIDES
145Pneumonia2041146CTD
146Post procedural complicationOFFSIDES
147PresbyopiaOFFSIDES
148Product quality issueOFFSIDES
149PurulenceOFFSIDES
150Purulent dischargeOFFSIDES
151Respiratory Tract Infections2041146CTD
152Salmonella infections9759304CTD
153Schizoaffective DisorderOFFSIDES
154ScreamingCanada Vigilance: 2Canada Vigilance
155Sense of oppressionOFFSIDES
156ShockSIDER
157Skin hypertrophyOFFSIDES
158Skin necrosisOFFSIDES
159Streptococcal Infections2041146CTD
160SuperinfectionSIDER
161Therapy non-responderOFFSIDES
162ThrombocytopeniaSIDER
163ThrombocytosisSIDER
164Tonsillitis2041146CTD
165Tracheal fistulaOFFSIDES
166Tympanic Membrane PerforationOFFSIDES
167Urinary tract infectionSIDER
168Vestibular NeuronitisOFFSIDES
169Vitamin A DeficiencyOFFSIDES
170Walking aid userOFFSIDES
171furuncleOFFSIDES
172jaundiceSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.